Matches in SemOpenAlex for { <https://semopenalex.org/work/W2888433054> ?p ?o ?g. }
- W2888433054 endingPage "48" @default.
- W2888433054 startingPage "37" @default.
- W2888433054 abstract "It is an open issue whether blood biomarkers serve to diagnose Alzheimer’s disease (AD) or monitor its progression over time from prodromal stages. Here, we addressed this question starting from data of the European FP7 IMI-PharmaCog/E-ADNI longitudinal study in amnesic mild cognitive impairment (a MCI) patients including biological, clinical, neuropsychological (e.g., ADAS-Cog13), neuroimaging, and electroencephalographic measures. PharmaCog/E-ADNI patients were classified as “positive” (i.e., “prodromal AD” n = 76) or “negative” (n = 52) based on a diagnostic cut-off of Aβ42/P-tau in cerebrospinal fluid as well as APOE ε 4 genotype. Blood was sampled at baseline and at two follow-ups (12 and 18 months), when plasma amyloid peptide 42 and 40 (Aβ42, Aβ40) and apolipoprotein J (clusterin, CLU) were assessed. Linear Mixed Models found no significant differences in plasma molecules between the “positive” (i.e., prodromal AD) and “negative” groups at baseline. In contrast, plasma Aβ42 showed a greater reduction over time in the prodromal AD than the “negative” aMCI group (p = 0.048), while CLU and Aβ40 increased, but similarly in the two groups. Furthermore, plasma Aβ42 correlated with the ADAS-Cog13 score both in aMCI patients as a whole and the prodromal AD group alone. Finally, CLU correlated with the ADAS-Cog13 only in the whole aMCI group, and no association with ADAS-Cog13 was found for Aβ40. In conclusion, plasma Aβ42 showed disease progression-related features in aMCI patients with prodromal AD." @default.
- W2888433054 created "2018-08-31" @default.
- W2888433054 creator A5005536123 @default.
- W2888433054 creator A5007801159 @default.
- W2888433054 creator A5007909621 @default.
- W2888433054 creator A5008752460 @default.
- W2888433054 creator A5008906120 @default.
- W2888433054 creator A5019846852 @default.
- W2888433054 creator A5024471384 @default.
- W2888433054 creator A5027464378 @default.
- W2888433054 creator A5028038591 @default.
- W2888433054 creator A5031923377 @default.
- W2888433054 creator A5036068671 @default.
- W2888433054 creator A5042710338 @default.
- W2888433054 creator A5045491539 @default.
- W2888433054 creator A5045793605 @default.
- W2888433054 creator A5055366347 @default.
- W2888433054 creator A5058425813 @default.
- W2888433054 creator A5062687221 @default.
- W2888433054 creator A5062777125 @default.
- W2888433054 creator A5068354706 @default.
- W2888433054 creator A5071350557 @default.
- W2888433054 creator A5074115401 @default.
- W2888433054 creator A5079246880 @default.
- W2888433054 creator A5079806242 @default.
- W2888433054 creator A5080766962 @default.
- W2888433054 creator A5081024703 @default.
- W2888433054 creator A5084544899 @default.
- W2888433054 creator A5086914602 @default.
- W2888433054 creator A5088896716 @default.
- W2888433054 date "2019-05-07" @default.
- W2888433054 modified "2023-10-13" @default.
- W2888433054 title "Plasma Aβ42 as a Biomarker of Prodromal Alzheimer’s Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study" @default.
- W2888433054 cites W1208364757 @default.
- W2888433054 cites W1963687105 @default.
- W2888433054 cites W1979121852 @default.
- W2888433054 cites W2018880103 @default.
- W2888433054 cites W2019244067 @default.
- W2888433054 cites W2029445248 @default.
- W2888433054 cites W2041004450 @default.
- W2888433054 cites W2065514214 @default.
- W2888433054 cites W2065929647 @default.
- W2888433054 cites W2116709840 @default.
- W2888433054 cites W2127108221 @default.
- W2888433054 cites W2155087576 @default.
- W2888433054 cites W2167538572 @default.
- W2888433054 cites W2203678334 @default.
- W2888433054 cites W2207268297 @default.
- W2888433054 cites W2289673868 @default.
- W2888433054 cites W2308823953 @default.
- W2888433054 cites W2414917913 @default.
- W2888433054 cites W2488678869 @default.
- W2888433054 cites W2524942052 @default.
- W2888433054 cites W2569666510 @default.
- W2888433054 cites W2572249372 @default.
- W2888433054 cites W2607110682 @default.
- W2888433054 cites W2618496875 @default.
- W2888433054 cites W2720950465 @default.
- W2888433054 cites W2734510557 @default.
- W2888433054 cites W2736518852 @default.
- W2888433054 cites W2750795037 @default.
- W2888433054 cites W2754872649 @default.
- W2888433054 cites W2765227162 @default.
- W2888433054 cites W2765322686 @default.
- W2888433054 cites W2772836221 @default.
- W2888433054 cites W2775139260 @default.
- W2888433054 cites W2778247735 @default.
- W2888433054 cites W2784222324 @default.
- W2888433054 cites W2784429314 @default.
- W2888433054 cites W2785757836 @default.
- W2888433054 cites W2794074331 @default.
- W2888433054 cites W2794628157 @default.
- W2888433054 cites W2795642715 @default.
- W2888433054 cites W2796338238 @default.
- W2888433054 cites W2798054687 @default.
- W2888433054 cites W2800072671 @default.
- W2888433054 cites W3214092816 @default.
- W2888433054 doi "https://doi.org/10.3233/jad-180321" @default.
- W2888433054 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30149449" @default.
- W2888433054 hasPublicationYear "2019" @default.
- W2888433054 type Work @default.
- W2888433054 sameAs 2888433054 @default.
- W2888433054 citedByCount "20" @default.
- W2888433054 countsByYear W28884330542019 @default.
- W2888433054 countsByYear W28884330542020 @default.
- W2888433054 countsByYear W28884330542021 @default.
- W2888433054 countsByYear W28884330542022 @default.
- W2888433054 countsByYear W28884330542023 @default.
- W2888433054 crossrefType "journal-article" @default.
- W2888433054 hasAuthorship W2888433054A5005536123 @default.
- W2888433054 hasAuthorship W2888433054A5007801159 @default.
- W2888433054 hasAuthorship W2888433054A5007909621 @default.
- W2888433054 hasAuthorship W2888433054A5008752460 @default.
- W2888433054 hasAuthorship W2888433054A5008906120 @default.
- W2888433054 hasAuthorship W2888433054A5019846852 @default.
- W2888433054 hasAuthorship W2888433054A5024471384 @default.
- W2888433054 hasAuthorship W2888433054A5027464378 @default.
- W2888433054 hasAuthorship W2888433054A5028038591 @default.